Zydus Cadila receives USFDA approval to market Benazepril

New Delhi, May 26 (UNI) Zydus Cadila today said it has received its 38th Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) to market 5mg, 10mg, 20mg and 40mg Benazepril tablets used in the treatment of cardiovascular disorders.

''The drug falls in the cardiovascular segment and the combined sales of all the strengths as per NDC is estimated at 301 million dollars in 2007,'' the company said in a statement.

UNI AK SG DS1515